• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NFATc2和NFKB1/RELA对Ets1表达的上调促进乳腺癌细胞的侵袭性。

Upregulation of Ets1 expression by NFATc2 and NFKB1/RELA promotes breast cancer cell invasiveness.

作者信息

Kim Gi-Cheon, Kwon Ho-Keun, Lee Choong-Gu, Verma Ravi, Rudra Dipayan, Kim Taemook, Kang Keunsoo, Nam Jong Hee, Kim Young, Im Sin-Hyeog

机构信息

Division of Integrative Biosciences and Biotechnology (IBB), Department of Life Sciences, Pohang University of Science and Technology, Pohang, 37673, Republic of Korea.

Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, 02115, USA.

出版信息

Oncogenesis. 2018 Nov 23;7(11):91. doi: 10.1038/s41389-018-0101-3.

DOI:10.1038/s41389-018-0101-3
PMID:30467308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6250664/
Abstract

Breast cancer is highly aggressive and is the leading cause of cancer-related mortality in women in developed countries. The ETS proto-oncogene 1 (Ets1) has versatile roles during the cellular processes of cancer development. It is often highly expressed in breast cancers and mediates migration and invasion of human breast cancer cells. However, underlying mechanisms of Ets1 gene expression is still ambiguous. Here, we identified a core-regulatory element (CRE) located in the Ets1 promoter region (-540/-80 bp from TSS) that contains elements responsible for associating with NFATs and NF-κBs. Compared with the less metastatic breast cancer cells, metastatic breast cancer cells (MDA-MB-231) show open chromatin configurations in the CRE, which facilitates direct binding of NFATc2 and/or NFKB1/RELA complex to trans-activate Ets1 transcription. Moreover, enhanced level of Nfatc2 and Nfkb1 positively correlated with Ets1 expression in the human breast cancer specimens. Deletion of the CRE region by CRISPR/Cas9 system resulted in significant reduction in Ets1 expression, which led to alterations of Ets1-mediated transcription programs including tumor invasiveness-related genes. Proper regulation of Ets1 gene expression by targeting the NFATc2 and NFKB1/RELA interaction could be a potential therapeutic target for Ets1-mediated metastatic breast cancer.

摘要

乳腺癌具有高度侵袭性,是发达国家女性癌症相关死亡的主要原因。ETS原癌基因1(Ets1)在癌症发展的细胞过程中具有多种作用。它在乳腺癌中通常高度表达,并介导人乳腺癌细胞的迁移和侵袭。然而,Ets1基因表达的潜在机制仍不明确。在这里,我们在Ets1启动子区域(距转录起始位点-540/-80 bp)鉴定了一个核心调控元件(CRE),该元件包含负责与NFAT和NF-κB结合的元件。与低转移性乳腺癌细胞相比,转移性乳腺癌细胞(MDA-MB-231)在CRE中显示出开放的染色质结构,这有利于NFATc2和/或NFKB1/RELA复合物直接结合以反式激活Ets1转录。此外,在人乳腺癌标本中,Nfatc2和Nfkb1水平的升高与Ets1表达呈正相关。通过CRISPR/Cas9系统缺失CRE区域导致Ets1表达显著降低,这导致了包括肿瘤侵袭相关基因在内的Ets1介导的转录程序的改变。通过靶向NFATc2和NFKB1/RELA相互作用来适当调节Ets1基因表达可能是Ets1介导的转移性乳腺癌的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc2/6250664/fa666ffe92da/41389_2018_101_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc2/6250664/e2dd5544d573/41389_2018_101_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc2/6250664/48d75e9d5a4a/41389_2018_101_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc2/6250664/7592aca6b0e1/41389_2018_101_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc2/6250664/d245e2c26e72/41389_2018_101_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc2/6250664/fa666ffe92da/41389_2018_101_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc2/6250664/e2dd5544d573/41389_2018_101_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc2/6250664/48d75e9d5a4a/41389_2018_101_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc2/6250664/7592aca6b0e1/41389_2018_101_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc2/6250664/d245e2c26e72/41389_2018_101_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fc2/6250664/fa666ffe92da/41389_2018_101_Fig5_HTML.jpg

相似文献

1
Upregulation of Ets1 expression by NFATc2 and NFKB1/RELA promotes breast cancer cell invasiveness.NFATc2和NFKB1/RELA对Ets1表达的上调促进乳腺癌细胞的侵袭性。
Oncogenesis. 2018 Nov 23;7(11):91. doi: 10.1038/s41389-018-0101-3.
2
ETS1 Suppresses Tumorigenesis of Human Breast Cancer via Trans-Activation of Canonical Tumor Suppressor Genes.ETS1通过经典肿瘤抑制基因的反式激活抑制人乳腺癌的肿瘤发生。
Front Oncol. 2020 May 14;10:642. doi: 10.3389/fonc.2020.00642. eCollection 2020.
3
Long non-coding RNA PAXIP1-AS1 facilitates cell invasion and angiogenesis of glioma by recruiting transcription factor ETS1 to upregulate KIF14 expression.长链非编码 RNA PAXIP1-AS1 通过募集转录因子 ETS1 上调 KIF14 表达促进胶质瘤细胞侵袭和血管生成。
J Exp Clin Cancer Res. 2019 Dec 10;38(1):486. doi: 10.1186/s13046-019-1474-7.
4
Protein kinase Calpha regulates Ets1 transcriptional activity in invasive breast cancer cells.蛋白激酶Cα调节侵袭性乳腺癌细胞中的Ets1转录活性。
Int J Oncol. 2003 Apr;22(4):799-805.
5
Importance of ets1 proto-oncogene for breast cancer progression.ets1原癌基因对乳腺癌进展的重要性。
Zentralbl Gynakol. 2004 Aug;126(4):269-71. doi: 10.1055/s-2004-822758.
6
Splicing variant DeltaVII-Ets1 is downregulated in invasive Ets1-expressing breast cancer cells.剪接变体DeltaVII-Ets1在侵袭性表达Ets1的乳腺癌细胞中表达下调。
Int J Oncol. 2003 Apr;22(4):849-53.
7
PAX3 and ETS1 synergistically activate MET expression in melanoma cells.PAX3和ETS1协同激活黑色素瘤细胞中的MET表达。
Oncogene. 2015 Sep 17;34(38):4964-74. doi: 10.1038/onc.2014.420. Epub 2014 Dec 22.
8
ETS1 promotes chemoresistance and invasion of paclitaxel-resistant, hormone-refractory PC3 prostate cancer cells by up-regulating MDR1 and MMP9 expression.ETS1 通过上调 MDR1 和 MMP9 的表达促进紫杉醇耐药、激素难治性 PC3 前列腺癌细胞的化疗耐药和侵袭。
Biochem Biophys Res Commun. 2012 Jan 20;417(3):966-71. doi: 10.1016/j.bbrc.2011.12.047. Epub 2011 Dec 20.
9
ETS1 regulates Twist1 transcription in a Kras/Lkb1 metastatic lung tumor model of non-small cell lung cancer.ETS1 在非小细胞肺癌的 Kras/Lkb1 转移性肺肿瘤模型中调节 Twist1 的转录。
Clin Exp Metastasis. 2018 Mar;35(3):149-165. doi: 10.1007/s10585-018-9912-z. Epub 2018 Jun 16.
10
ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells.ETS1 诱导转化生长因子 β 信号通路并促进前列腺癌细胞的上皮间质转化。
J Cell Biochem. 2019 Jan;120(1):848-860. doi: 10.1002/jcb.27446. Epub 2018 Aug 30.

引用本文的文献

1
Dishevelled-1 regulates global transcriptomic changes and associates with ETS1 transcription factor.Dishevelled-1调节整体转录组变化并与ETS1转录因子相关联。
Nat Commun. 2025 Jul 8;16(1):6288. doi: 10.1038/s41467-025-61551-1.
2
Single cell sequencing and computational findings reveal anti-estrogen receptor-positive breast cancer roles of formononetin.单细胞测序和计算结果揭示了芒柄花素在抗雌激素受体阳性乳腺癌中的作用。
Sci Rep. 2025 Jul 1;15(1):20892. doi: 10.1038/s41598-025-06133-3.
3
Long non-coding RNA-MIR181A1HG acts as an oncogene and contributes to invasion and metastasis in gastric cancer.

本文引用的文献

1
Statins affect ETS1-overexpressing triple-negative breast cancer cells by restoring DUSP4 deficiency.他汀类药物通过恢复 DUSP4 缺陷来影响 ETS1 过表达的三阴性乳腺癌细胞。
Sci Rep. 2016 Sep 8;6:33035. doi: 10.1038/srep33035.
2
MMP14 regulates cell migration and invasion through epithelial-mesenchymal transition in nasopharyngeal carcinoma.基质金属蛋白酶14通过上皮-间质转化调控鼻咽癌的细胞迁移和侵袭。
Am J Transl Res. 2015 May 15;7(5):950-8. eCollection 2015.
3
Somatic Cell Fusions Reveal Extensive Heterogeneity in Basal-like Breast Cancer.
长链非编码RNA-MIR181A1HG作为一种癌基因,促进胃癌的侵袭和转移。
Oncogene. 2025 Jun;44(20):1517-1529. doi: 10.1038/s41388-025-03323-1. Epub 2025 Mar 5.
4
Nuclear Factor of Activated T Cells (NFAT) Proteins as Targeted Molecules in Diseases: A Narrative Review.活化T细胞核因子(NFAT)蛋白作为疾病中的靶向分子:一篇叙述性综述。
Cureus. 2024 Dec 16;16(12):e75844. doi: 10.7759/cureus.75844. eCollection 2024 Dec.
5
NFKB1 as a key player in Tumor biology: from mechanisms to therapeutic implications.NFKB1作为肿瘤生物学中的关键角色:从机制到治疗意义
Cell Biol Toxicol. 2025 Jan 11;41(1):29. doi: 10.1007/s10565-024-09974-2.
6
PARP-1 Inhibition Increases Oxidative Stress in Ets-1-Expressing MDA-MB-231 Breast Cancer Cells.PARP-1抑制作用增加表达Ets-1的MDA-MB-231乳腺癌细胞中的氧化应激。
Cancer Rep (Hoboken). 2025 Jan;8(1):e70119. doi: 10.1002/cnr2.70119.
7
HYPOXIA induces lncRNA HOTAIR for recruiting RELA in papillary thyroid cancer cells to upregulate miR-181a and promote angiogenesis.缺氧诱导长链非编码 RNA HOTAIR 募集 RELA 在甲状腺乳头状癌细胞中上调 miR-181a 并促进血管生成。
J Endocrinol Invest. 2024 Nov;47(11):2873-2884. doi: 10.1007/s40618-024-02388-1. Epub 2024 May 15.
8
Genetic analysis of PALB2 gene WD40 domain in canine mammary tumour patients.犬乳腺肿瘤患者 PALB2 基因 WD40 结构域的遗传分析。
Vet Med Sci. 2024 May;10(3):e1366. doi: 10.1002/vms3.1366.
9
Identification of hub genes to determine drug-disease correlation in breast carcinomas.鉴定枢纽基因以确定乳腺癌中的药物-疾病相关性。
Med Oncol. 2023 Dec 28;41(1):36. doi: 10.1007/s12032-023-02246-9.
10
A Bayesian framework for pathway-guided identification of cancer subgroups by integrating multiple types of genomic data.基于贝叶斯框架,通过整合多种类型的基因组数据,对癌症亚组进行通路指导的识别。
Stat Med. 2023 Dec 10;42(28):5266-5284. doi: 10.1002/sim.9911. Epub 2023 Sep 15.
体细胞融合揭示基底样乳腺癌的广泛异质性。
Cell Rep. 2015 Jun 16;11(10):1549-63. doi: 10.1016/j.celrep.2015.05.011. Epub 2015 Jun 4.
4
NFAT1 and JunB cooperatively regulate IL-31 gene expression in CD4+ T cells in health and disease.在健康和疾病状态下,NFAT1和JunB协同调节CD4+ T细胞中IL-31基因的表达。
J Immunol. 2015 Feb 15;194(4):1963-74. doi: 10.4049/jimmunol.1401862. Epub 2015 Jan 16.
5
NF-κB affects proliferation and invasiveness of breast cancer cells by regulating CD44 expression.核因子-κB通过调节CD44的表达影响乳腺癌细胞的增殖和侵袭能力。
PLoS One. 2014 Sep 3;9(9):e106966. doi: 10.1371/journal.pone.0106966. eCollection 2014.
6
JARID1B is a luminal lineage-driving oncogene in breast cancer.JARID1B 是乳腺癌中管腔谱系驱动的癌基因。
Cancer Cell. 2014 Jun 16;25(6):762-77. doi: 10.1016/j.ccr.2014.04.024.
7
The emerging role of MMP14 in brain tumorigenesis and future therapeutics.基质金属蛋白酶14在脑肿瘤发生及未来治疗中的新作用
Biochim Biophys Acta. 2014 Aug;1846(1):113-20. doi: 10.1016/j.bbcan.2014.03.002. Epub 2014 Mar 19.
8
Modeling precision treatment of breast cancer.乳腺癌精准治疗建模
Genome Biol. 2013;14(10):R110. doi: 10.1186/gb-2013-14-10-r110.
9
Hepatocyte growth factor-mediated gastrin-releasing peptide induces IL-8 expression through Ets-1 in gastric cancer cells.肝细胞生长因子介导的胃泌素释放肽通过 Ets-1 在胃癌细胞中诱导 IL-8 的表达。
Oncol Res. 2013;20(9):393-402. doi: 10.3727/096504013X13657689382770.
10
APOBEC3B is an enzymatic source of mutation in breast cancer.APOBEC3B 是乳腺癌突变的酶源。
Nature. 2013 Feb 21;494(7437):366-70. doi: 10.1038/nature11881. Epub 2013 Feb 6.